By Chicago Tribune |
December 11, 2019
Former Outcome Health executive Ashik Desai entered the first guilty plea Monday in an alleged $1 billion fraud scheme at the once high-flying Chicago-based company. A federal prosecutor said Desai is cooperating with the government’s investigation.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders.
One of the most important elements of a company’s success is also one of the least tangible —culture.